Effects of melatonin in vivo upon luteinizing hormone and prolactin releases induced by opiate receptor antagonists in adult male rats

Journal of Endocrinological Investigation

Volumn 19, Issue 2, 1996, Pages 76-82

  Shacoori, V ^a   Saiag B ^a   Lemay, V ^a   Girre, A ^a   Rault, B ^a  

^a Institute de Chimie de'Rennes   (France)

Author keywords

Luteinizing hormone; Melatonin; Nalmefene; Naloxone; Naloxone methyliodide; Prolactin; Rat

Indexed keywords

17 METHYLNALOXONE; LUTEINIZING HORMONE; MELATONIN; NALMEFENE; NALOXONE; OPIATE ANTAGONIST; OPIATE RECEPTOR; PROLACTIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; LUTEINIZING HORMONE RELEASE; MALE; NONHUMAN; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; RAT;

EID: 0029912990     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03349840     Document Type: Article

References (40)

1. Milan M.J., Herz A. The endocrinology of the opioids. Int. Rev. Neurobiol. 26: 1. 1985.
2. Gosselin R.E., Blankstein J., William Dent D., Hobson W.C., Fuller G.B., Reyes F.I., Winter J.S.D., Faiman C. Effects of naloxone and an enkephalin analog on serum prolactin, cortisol and gonadotropins in the chimpanzee. Endocrinology 112: 2168, 1983.
3. Van Vugt D.A., Webb M.Y., Reid R.L. Naloxone antagonism of corticotropin-releasing hormone stimulation of prolactin secretion in rhesus monkey. J. Clin. Endocrinol. Metab. 68: 1060, 1989.
4. Simpkins J.W., Swager D., Millard W.J. Evaluation of the sites of opioid influence on anterior pituitary hormone secretion using a quaternary opiate antagonist. Neuroendocrinology 54: 384, 1991.
5. Parrott R.F., Goode J.A. Central effects of naloxone and selected opioid agonists on cortisol and prolactin secretion in non-stressed sheep. Gen. Pharmacol. 24: 101, 1993.
6. Mieno M., Yamashita E.R., Iimori M., Yamashita K. An inhibitory effect of melatonin on the luteinizing hormone releasing activity of luteinizing hormone-releasing hormone in the immature male dogs. J. Endocrinol. 78: 283, 1978.
7. Aubert M.L., Rivest R.W., Lang U., Winiger B.P., Sizonenko P.C. Delayed sexual maturation induced by daily melatonin administration eliminates the LH response to naloxone despite normal responsiveness to GnRH in juvenile male rats. Neuroendocrinology 48: 72, 1988.
8. Steger R.W., Gay-Primel E. Effects of melatonin injections on the ability of golden hamster pituitaries to secrete prolactin and luteinizing hormone. Biol. Reprod. 42: 217, 1990.
9. Lissoni P., Esposti D., Esposti G., Mauri R., Resentini M., Morabito F., Fumagalli P., Santagostino A., Delitala G., Fraschini F. A clinical study on the relationship between the pineal gland and the opioid system. J. Neural. Transm. 65: 63, 1986.
10. Sandyk R., Fisher H. Melatonin potentiates the effects of naloxone on reserpin-induced catalepsy in the rat. Int. J. Neurosci. 48: 125, 1989.
11. Esposti D., Lissoni P., Mauri R., Rovelli F., Orsenigo L., Pescia S., Vegetti G., Esposti G., Fraschini F. The pineal gland-opioid system relation: melatoninnaloxone interaction in regulating GH and LH releases in man. J. Steroid. Biochem. 32(B): 145, 1988.
12. Trentini G.P., Genazzani A.R., Criscuolo M., Petraglia F., De Gaetani C., Ficarra G., Bidzinska B., Migaldi M. Melatonin treatment delays reproductive aging of female rat via the opiatergic system. Neuroendocrinology 56: 364, 1992.
13. Waldhauser F., Lieberman H.R., Lynch H.J., Waldhauser M., Herkner K., Frisch H., Vierhapper H., Waldhäusl W., Schemper M., Wurtman R.J., Crowley W.F. A pharmacological dose of melatonin increases PRL levels in males without altering those of GH, LH, FSH, TSH, testosterone or cortisol. Neuroendocrinology 46: 125, 1987.
14. Vaughan M.K., Blask D.E., Johnson L.Y., Reiter R.J. The effect of subcutaneous injections of melatonin, arginine vasotocin, and related peptides on pituitary and plasma levels of luteinizing hormone, follicle-stimulating hormone, and prolactin incastrated adulte male rats. Endocrinology 104: 212, 1979.
15. Kennaway D.J., Gilmore T.A., Seamark R.F. Effect of melatonin feeding on serum prolactin and gonadotropin levels and the onset of seasonal estrous cyclicity in sheep. Endocrinology 110: 2186, 1982.
16. Lincoln G.A. Administration of melatonin into the mediobasal hypothalamus as a continuous or intermittent signal affects the secretion of follicle stimulating hormone and prolactin in the ram. J. Pineal. Res. 12: 135, 1992.
17. Meunier M., Brebion P., Chêne N., Servely J.L., Martinet L. In vitro secretion of prolactin and growth hormone in the presence of melatonin by pituitary gland from mink kept under long or short days. J. Endocrinol. 119: 287, 1988.
18. Lamberts S.W.J., Macleod R.M. Regulation of prolactin secretion at the level of the lactotroph. Physiol. Rev. 70: 279, 1990.
19. Katovich M.J., Simpkins J.W., O'Meara J. Effects of opioid antagonists and their quaternary analogs on temperature changes in morphin-dependent rats. Life Sci. 39: 1845, 1986.
20. Bianchi G., Fiocchi R., Tavani A., Manora L. Quaternary narcotic antagonists' relative ability to prevent antinociception and gastrointestinal transit inhibition in morphin-treated rats as an index of peripheral selectivity. Life Sci. 30: 1875, 1982.
21. Limonta P., Bardin C.W., Hahn E.F., Thau R.B. Unexpected effects of nalmefene, a new opiate antagonist, on the hypothalamic-pituitary-gonadal axis in the male rat. Steroids 46: 955, 1985.
22. Vakkuri O., Leppalusto J., Vuoltunako O. Development and variation of a melatonin radioimmunoassay using radio-iodinated melatonin as tracer. Acta Endocrinol. (Copenh.) 106: 152, 1984.
23. Webley G.E., Mehl H., Willey K.P. Validation of a sensitive direct assay for melatonin for investigation of circadian rhythms in different species. J. Endocrinol. 106: 387, 1985.
24. Cicero T.J., Schainker B.A., Meyer E.R. Endogenous opioids participate in the regulation of the hypothalamic-pituitary-luteinizing hormone axis and testosterone's negative feedback control of luteinizing hormone. Endocrinology 104: 1286, 1979.
25. Akabori A., Barraclough C.A. Gonadotropin responses to naloxone may depend upon spontaneous activity in noradrenergic neurons at the time of treatment. Brain Res. 362: 55, 1986.
26. Blank M.S., Panerai A.E., Friesen H.G. Effects of naloxone on luteinizing hormone and prolactin in serum of rats. J. Endocrinol. 85: 307, 1980.
27. Wang J.B., Johnson P.S., Persico A.M., Hawkins A.L., Griffin C.A., Uhi G.R. Human μ opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Lett. 338: 217, 1994.
28. Dubocovich M.L. Melatonin receptors: are there multiple subtypes? TIPS 16: 50, 1995.
29. Zisapel N., Egozi Y., Laudon M. Circadian variation in the inhibition of dopamine release from adult and newborn rat hypothalamus by melatonin. Neuroendocrinology 40: 102, 1985.
30. Tamarkin L., Westrom W.K., Hamill A.L., Goldman B.D. Effect of melatonin on the reproductive systems of male and female Syrian hamsters: a diurnal rhythme in sensitivity to melatonin. Endocrinology 99: 1534, 1976.
31. Shacoori V., Giquel J.Y., Saïag B., Rault B. Effect of an acute pharmacological dose of melatonin in vivo upon LH release induced by naloxone and naltrexone. Res. Commun. Subs. Abuse. 2-3: 169, 1993.
32. Lincoln G.A., Maeda K.I. Effects of placing micro-implants of melatonin in the mediobasal hypothalamus and preoptic area on the secretion of prolactin and β-endorphin in rams. J. Endocrinol. 134: 437, 1992.
33. Masotto C., Negro-Vilar A. Activation of gamma aminobutyric acid β-receptors abolishes naloxone-stimulated luteinizing hormone release. Endocrinology 121: 2251, 1987.
34. Kim K., Lee C.C., Cho W.K., Ramirez V.D. Adrenergic mediation of the naloxone-induced GnRH release from hypothalami of ovariectomized, steroid-treated immature rats. Acta Endocrinol. (Copenh.) 125: 680, 1991.
35. Zisapel N., Laudon M. Dopamine release induced by electrical field stimulation of rat hypothalamus in vitro: inhibition by melatonin. Biochem. Biophys. Res. Commun. 104: 1610, 1982.
36. Moguilevsky J.A., Scacchi P., Deis R., Siseles N.O. Effect of melatonin on the luteinizing hormone release induced by clomiphene and luteinizing hormone-releasing hormone. Proc. Soc. Exp. Biol. Med. 151: 663, 1976.
37. Vaughan M.K., Little J.C., Johnson L.Y., Blask D.E., Vaughan G.M., Reiter R.J. Effects of melatonin and natural and synthetic analogues of arginine vasotocin on prolactin levels in adult male rats. Norm. Res. 9: 236, 1978.
38. Fudala P.J., Heishman S.J., Henninfield U.E., Johnson R.E. Human pharmacology and abuse potential of nalmefene. Clin. Pharmacol. Ther. 49: 300, 1991.
39. Malpaux B., Daveau A., Maurice F., Locatelli A., Thiery U.C. Evidence that melatonin binding sites in the pars tuberalis do not mediate the photoperiodic actions of melatonin on LH and prolactin secretion in ewes. J. Reprod. Fert. 101(3): 625, 1994.
40. Rasmussen D.D. The interaction between mediobasohypothalamic dopaminergic and endorphinergic neuronal systems as a key regulator of reproduction: an hypothesis. J. Endocrinol. Invest. 14: 323, 1991.